Leena Gandhi
Physician · Dana-Farber Cancer Institute
Credentials: · · · ·
History
- 2020–Present
- 2005–2008
Hematology and Medical Oncology
- 2002–2005
Internal Medicine
Research
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2018 · First of 30 authors · 5,534 citations
Pembrolizumab for the treatment of non-small-cell lung cancer
New England Journal of Medicine · 2015 · 5,237 citations
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
New England Journal of Medicine · 2010 · 3,649 citations
12 papers
11 papers
- AP
9 papers
9 papers
8 papers
8 papers
8 papers
8 papers
Clinical trials
- 2017
Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer
Study chair · Completed · Phase 1, Phase 2
Ludwig Institute for Cancer Research
- 2024–2027
A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
Study director · Recruiting · Phase 1
NextPoint Therapeutics, Inc.
- 2023–2025
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
Study director · Suspended · Phase 1
NextPoint Therapeutics, Inc.